Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 7:48 pm Sale | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Point72 Asset Management L.P. | 0 0.000% | -388,676 (Position Closed) | View |
| 2024-11-14 6:41 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ORBIMED ADVISORS LLC | 589,200 4.900% | 589,200 (New Position) | View |
| 2024-11-14 4:05 pm Sale | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 2,873 0.020% | -339,240 (-99.16%) | View |
| 2024-11-14 4:00 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | TANG CAPITAL MANAGEMENT LLC | 600,000 4.980% | 600,000 (New Position) | View |
| 2024-11-14 3:09 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Asset Management LP | 2,375,000 19.500% | 350,000 (+17.28%) | View |
| 2024-11-12 2:34 pm Unchanged | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | VANGUARD GROUP INC | 645,650 5.360% | 0 (Unchanged) | View |
| 2024-11-12 09:37 am Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Adage Capital Management L.P. | 528,937 4.390% | 528,937 (New Position) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | BlackRock Inc. | 802,721 6.700% | 0 (Unchanged) | View |
| 2024-11-04 11:28 am Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | VANGUARD GROUP INC | 645,650 5.360% | 645,650 (New Position) | View |
| 2024-10-22 6:06 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | BlackRock Inc. | 802,721 6.700% | 802,721 (New Position) | View |
| 2024-10-15 4:19 pm Sale | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | MILLENNIUM MANAGEMENT LLC | 122,751 1.000% | -421,525 (-77.45%) | View |
| 2024-10-11 4:02 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Octagon Capital Advisors LP | 1,115,000 9.300% | 1,115,000 (New Position) | View |
| 2024-03-18 4:11 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Asset Management LP | 2,025,000 19.300% | 2,025,000 (New Position) | View |
| 2024-02-28 4:38 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | MILLENNIUM MANAGEMENT LLC | 544,276 5.300% | 544,276 (New Position) | View |
| 2024-02-14 4:45 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 342,113 7.500% | 342,113 (New Position) | View |
| 2024-02-14 4:41 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 10,524,401 7.800% | 10,524,401 (New Position) | View |
| 2024-02-14 4:08 pm Sale | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Paradigm Biocapital Advisors LP | 0 0.000% | -399,658 (Position Closed) | View |
| 2024-02-12 4:42 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | ADAGE CAPITAL PARTNERS GP L.L.C. | 796,392 7.700% | 796,392 (New Position) | View |
| 2024-02-12 4:18 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | RA CAPITAL MANAGEMENT L.P. | 430,182 4.100% | 430,182 (New Position) | View |
| 2024-02-09 4:11 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | INTEGRATED CORE STRATEGIES (US) LLC | 419,707 4.100% | 419,707 (New Position) | View |